Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds ...

In August 2024, Madhabi Puri Buch, then-chairperson of India’s market regulator Securities and Exchange Board of India (Sebi) ...

SEBI’s response clarifies that no additional compliance burden has been imposed through the 2024 amendments, maintaining existing requirements for listed companies, intermediaries, and fiduciaries.

One of the key factors was its decision to change the expiry for the Sensex F&O contract from Thursdays to Fridays. Following ...

The so-called 'product suitability framework' has not come up for discussions in recent meetings at Sebi, and there has been ...

SEBI may require retail F&O traders to pass a suitability test, ensuring they understand risks. Discover more on this ...

SEBI clarified that Angel Funds can invest only in startups meeting the Department for Promotion of Industry and Internal Trade (DPIIT) criteria. If a portfolio company loses its startup status, Angel ...

Market regulator's gross position limits for derivatives may lead to job losses, impact levies, and discourage hedging.

SEBI tightens SME IPO norms to protect investors, increase transparency, and ensure financial stability, sparking mixed ...

Separately, the regulator has provided flexibility of allotment to specific investors in the rights issue and discontinued ...

The IPO is expected to be one of the largest in the Indian market this year and marks a significant step for LG Electronics ...

Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds ...